Europe Clinical Trials Market Size, Share & Trends Analysis Report By Study Design (Interventional, Observational, Expanded Access), By Phase (Phase I, Phase II, Phase III, Phase IV), By Region, And Segment Forecasts, 2022 - 2030

Table of Content

Chapter 1 Methodology and Scope
                  1.1 Market Segmentation & Scope
                      1.1.1 Study Design
                      1.1.2 Phase
                      1.1.3 Country Scope
                      1.1.4 Estimates And Forecast Timeline
                  1.2 Research Methodology
                  1.3 Information Procurement
                      1.3.1 Purchased Database
                      1.3.2 GVR’s Internal Database
                      1.3.3 Secondary Sources
                      1.3.4 Primary Research
                      1.3.5 Details Of Primary Research
                  1.4 Information or Data Analysis
                      1.4.1 Data analysis models
                  1.5 Market Formulation & Validation
                  1.6 Model Details
                      1.6.1 Commodity Flow Analysis (Model 1)
                      1.6.2 Volume Price Analysis (Model 2)
                  1.7 List of Secondary Sources
                  1.8 List of Primary Sources
                  1.9 List of Abbreviations
                  1.10 Objectives
                      1.10.1 Objective - 1: Understanding the market dynamics
                      1.10.2 Objective - 2: Understanding the market estimates and forecasts
                      1.10.3 Objective - 3: Understanding the attributes such as strategy framework
                      1.10.4 Objective - 4: Understanding the key service and application scopes to conclude on the market size
Chapter 2 Executive Summary
                  2.1 Market Outlook
                  2.2 Segment Outlook
Chapter 3 Europe Clinical Trials Market: Variables, Trends & Scope
                  3.1 Market Lineage Outlook
                      3.1.1 PARENT Market OUTLOOK
                  3.2 Penetration & Growth Prospect Mapping
                  3.3 Market Dynamics
                      3.3.1 Market Driver Analysis
                          3.3.1.1 Growing Adoption Of New Technology In Clinical Research
                          3.3.1.2 Shift Toward Personalized Medicine
                          3.3.1.3 Growing Disease Variation And Prevalence
                          3.3.1.4 Growth In Cro Market
                      3.3.2 Market Restraint Analysis
                          3.3.2.1 Regulations In New Drug Development
                          3.3.2.2 Regulations In New Drug Development
                          3.3.2.3 Pricing Pressure
                  3.4. Clinical Category Drivers & Restraints
                  3.5 Europe clinical trials Market: Analysis Tools
                      3.5.1 Porter’s Five Forces Analysis
                      3.5.2 Pestel Analysis
                      3.5.3 Major Deals & Strategic Alliances Analysis
                  3.6 Analysis of Total Number of Clinical Trial Studies Conducted, by Countries
                      3.6.1 Analysis of Total Number of Clinical Trial Studies Conducted, by Countries
                  3.7 Cost Breakdown analysis for CRO's
                      3.7.1 Percent Of Outsourced Vs In-House Clinical Trial Categories
                      3.7.2 Cost Breakdown Analysis For Cro's By Phase I, II, & III
                      3.7.3 Cost Breakdown Analysis For Cro's By Phase I, II, & III FOR Germany
                  3.8 Covid-19 Impact Analysis
Chapter 4 Europe clinical trials Market: Study Design Segment Analysis
                  4.1 Europe Clinical Trials Market: Definition & Scope
                  4.2 Europe Clinical Trials Market: Market Share Analysis, 2021 & 2030
                  4.3 Interventional Trials
                      4.3.1 Interventional trials studies market, 2018 - 2030 (USD Million)
                  4.4 Observational Trials
                      4.4.1 Observational trials studies market, 2018 - 2030 (USD Million)
                  4.5 Expanded access Trials
                      4.5.1 Expanded access studies market, 2018 - 2030 (USD Million)
Chapter 5 Europe clinical trials Market: Phase Segment Analysis
                  5.1 Europe clinical trials Market: Definition & Scope
                  5.2 Europe clinical trials Market: Market Share Analysis, 2021 & 2030
                  5.3 Phase I
                      5.3.1 Phase I market, 2018 - 2030 (USD Million)
                  5.4 Phase II
                      5.4.1 Phase II market, 2018 - 2030 (USD Million)
                  5.5 Phase III
                      5.5.1 Phase III market, 2018 - 2030 (USD Million)
                  5.6 Phase IV
                      5.6.1 Phase IV market, 2018 - 2030 (USD Million)
Chapter 6 Europe Clinical Trials Market: Country Analysis
                  6.1 Europe clinical trials Market: Definition & Scope
                  6.2 Country Market Snapshot
                  6.3 Country Market Share and Leading Players, 2020
                      6.3.1 U.K.
                      6.3.2 Germany
                      6.3.3 France
                      6.3.4 Italy
                      6.3.5 Spain
                  6.4 Europe clinical trials Market: Market Share Analysis, 2021 & 2030
                  6.5 Europe
                      6.5.1 Europe Europe clinical trials market, 2018 - 2030 (USD Million)
                      6.5.2 U.K.
                          6.5.2.1 U.K. Europe clinical trials market, 2018 - 2030 (USD Million)
                      6.5.3 Germany
                          6.5.3.1 Germany Europe clinical trials market, 2018 - 2030 (USD Million)
                      6.5.4 France
                          6.5.4.1 France Europe clinical trials market, 2018 - 2030 (USD Million)
                      6.5.5 Italy
                          6.5.5.1 Italy Europe clinical trials market, 2018 - 2030 (USD Million)
                      6.5.6 Spain
                          6.5.6.1 Spain Europe clinical trials market, 2018 - 2030 (USD Million)
Chapter 7 Company Profiles
                  7.1 IQVIA Holdings, Inc.,
                      7.1.1Company Overview
                      7.1.2 Financial Performance
                      7.1.3 Service Benchmarking
                      7.1.4 Strategic Initiatives
                  7.2 Parexel International Corporation
                      7.2.1 Company Overview
                      7.2.2 Service Benchmarking
                      7.2.3 Strategic Initiatives
                  7.3 PPD, Inc.
                      7.3.1 Company Overview
                      7.3.2 Financial Performance
                      7.3.3 Service Benchmarking
                      7.3.4 Strategic Initiatives
                  7.4 Syneos Health
                      7.4.1 Company Overview
                      7.4.2 Financial Performance
                      7.4.3 Service Benchmarking
                      7.4.4 Strategic Initiatives
                  7.5 Eli Lilly and Company
                      7.5.1 Company Overview
                      7.5.2 Financial Performance
                      7.5.3 Service Benchmarking
                      7.5.4 Strategic Initiatives
                  7.6 Novo Nordisk A/S
                      7.6.1 Company Overview
                      7.6.2 Financial Performance
                      7.6.3 Service Benchmarking
                      7.6.4 Strategic Initiatives
                  7.7 Pfizer, Inc.
                      7.7.1 Company Overview
                      7.7.2 Financial Performance
                      7.7.3 Service Benchmarking
                      7.7.4 Strategic Initiatives
                  7.8 Dr. Notghi Contract Research GmbH
                      7.8.1 Company Overview
                      7.8.2 Financial Performance
                      7.8.3 Service Benchmarking
                  7.9 Charite Research Organisation GmbH
                      7.9.1 Company Overview
                      7.9.2 Financial Performance
                      7.9.3 Service Benchmarking
                      7.9.4 Strategic Initiatives
                  7.10 Janssen Global Services, LLC
                      7.10.1 Company Overview
                      7.10.2 Service Benchmarking
                      7.10.3 Strategic Initiatives
                  7.11 Janssen Global Services, LLC
                      7.11.1 Company Overview
                      7.11.2 Financial Performance
                      7.11.3 Service Benchmarking
                      7.11.4 Strategic Initiatives
                  7.12 KFGN
                      7.12.1 Company Overview
                      7.12.2 Financial Performance
                      7.12.3 Service Benchmarking
                  7.13 Clariness
                      7.13.1 Company Overview
                      7.13.2 Service Benchmarking
                  7.14 Invisio Clinical Studies Consulting GmbH
                      7.14.1 Company Overview
                      7.14.2 Financial Performance
                      7.14.3 Service Benchmarking
Chapter 8 KOL Commentary
Chapter 9 Recommendations

List of Tables

Table 1 List of secondary sources
Table 2 List of Abbreviation
Table 3 List of Major Deals
Table 4 Average cost of clinical trials in major European countries
Table 5 Europe Clinical Trials Market, by Study Design, 2018 - 2030 (USD Million)
Table 6 Europe Clinical Trials Market, by Phase, 2018 - 2030 (USD Million)
Table 7 U.K. Clinical trials Market, by Country, 2018 - 2030 (USD Million)
Table 8 U.K. Clinical Trials Market, by Study Design, 2018 - 2030 (USD Million)
Table 9 U.K. Clinical Trials Market, by Phase, 2018 - 2030 (USD Million)
Table 10 Germany Clinical trials Market, by Country, 2018 - 2030 (USD Million)
Table 11 Germany Clinical Trials Market, by Study Design, 2018 - 2030 (USD Million)
Table 12 Germany Clinical Trials Market, by Phase, 2018 - 2030 (USD Million)
Table 13 France Clinical Trials Market, by Country, 2018 - 2030 (USD Million)
Table 14 France Clinical Trials Market, by Study Design, 2018 - 2030 (USD Million)
Table 15 France Clinical Trials Market, by Study Design, 2018 - 2030 (USD Million)
Table 16 Italy Clinical Trials Market, by Phase, 2018 - 2030 (USD Million)
Table 17 Italy Clinical Trials Market, by Country, 2018 - 2030 (USD Million)
Table 18 Italy Clinical Trials Market, by Study Design, 2018 - 2030 (USD Million)
Table 19 Spain Clinical Trials Market, by Phase, 2018 - 2030 (USD Million)
Table 20 Spain Clinical Trials Market, by Country, 2018 - 2030 (USD Million)
Table 21 Spain Clinical Trials Market, by Study Design, 2018 - 2030 (USD Million)

List of Figures

Fig. 1 Market Research Process
Fig. 2 Information of Procurement
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 QFD modeling for market share assessment
Fig. 6 Market formulation & validation
Fig. 7 Commodity flow analysis
Fig. 8 Volume price analysis
Fig. 9 Europe Clinical Trials Market snapshot (2021)
Fig. 10 Europe Clinical Trials Market segmentation
Fig. 11 Parent market outlook (2021)
Fig. 12 Penetration & growth prospect mapping
Fig. 13 Market driver relevance analysis (Current & future impact)
Fig. 14 Performance on precision medicine availability vs. Biomarker testing by country
Fig. 15 Market restraint relevance analysis (Current & future impact)
Fig. 16 Clinical Category Drivers & Restraints
Fig. 17 Porter’s five forces analysis
Fig. 18 SWOT analysis, by factor (political & legal, economic and technological)
Fig. 19 Germany Cost Per Indication (Million)
Fig. 20 U.K. Cost Per Indication (Million)
Fig. 21 France Cost Per Indication (Million)
Fig. 22 Italy Cost Per Indication (Million)
Fig. 23 Spain Cost Per Indication (Million)
Fig. 24 Total number of Clinical Trials By Country in 2021
Fig. 25 Europe (All Major Countries)
Fig. 26 Germany
Fig. 27 Europe (Average of all the major countries
Fig. 28 Percent of Outsourced vs In-house of Key Clinical Trial Categories (Trend across 2018-2020)
Fig. 29 Cost Breakdown by Phase I (Overall Europe)
Fig. 30 Cost Breakdown by Phase II (Overall Europe)
Fig. 31 Cost Breakdown by Phase III (Overall Europe)
Fig. 32 Cost Breakdown by Phase I (Germany)
Fig. 33 Cost Breakdown by Phase II (Germany)
Fig. 34 Cost Breakdown by Phase III (Germany)
Fig. 35 Europe Clinical Trials Market study design outlook: Segment dashboard
Fig. 36 Europe Clinical Trials Market: Study design movement analysis
Fig. 37 Interventional studies market, 2018 - 2030 (USD Million)
Fig. 38 Observational studies market, 2018 - 2030 (USD Million)
Fig. 39 Expanded access studies market, 2018 - 2030 (USD Million)
Fig. 40 Europe Clinical Trials Market phase outlook: Segment dashboard
Fig. 41 Europe Clinical Trials Market: Phase movement analysis
Fig. 42 Phase I market, 2018 - 2030 (USD Million)
Fig. 43 Phase II market, 2018 - 2030 (USD Million)
Fig. 44 Phase III market, 2018 - 2030 (USD Million)
Fig. 45 Phase IV market, 2018 - 2030 (USD Million)
Fig. 46 Country -wise market: Key takeaways
Fig. 47 Country outlook, 2021 & 2030
Fig. 48 Europe market, 2018 - 2030 (USD Million)
Fig. 49 U.K. market, 2018 - 2030 (USD Million)
Fig. 50 Germany market, 2018 - 2030 (USD Million)
Fig. 51 France market, 2018 - 2030 (USD Million)
Fig. 52 Italy market, 2018 - 2030 (USD Million)
Fig. 53 Spain market, 2018 - 2030 (USD Million)